Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible?
Wenke
K
K
Department of Cardiac Surgery, Munich-Bogenhausen, Germany.
Meiser
B
B
Thiery
J
J
Arndtz
N
N
von Scheidt
W
W
Seidel
D
D
Reichart
B
B
D000328:Adult; D003327:Coronary Disease / Q000517:prevention & control*; D016572:Cyclosporine / Q000097:blood; D005260:Female; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006084:Graft Rejection; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000628:therapy*; D008148:Lovastatin / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D019821:Simvastatin
D016572:Cyclosporine; D008148:Lovastatin; D019821:Simvastatin